113 related articles for article (PubMed ID: 21228609)
1. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.
Tulner DM; Smith OR; Schins A; de Jonge P; Quere M; Delanghe JR; Crijns HJ; den Boer JA; Korf J; Honig A
Neuropsychobiology; 2011; 63(3):169-76. PubMed ID: 21228609
[TBL] [Abstract][Full Text] [Related]
2. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Schins A; Hamulyák K; Scharpé S; Lousberg R; Van Melle J; Crijns H; Honig A
Life Sci; 2004 Dec; 76(6):637-50. PubMed ID: 15567189
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine: not a dual action antidepressant?
Gillman PK
Aust N Z J Psychiatry; 2004 Apr; 38(4):266-7. PubMed ID: 15038808
[No Abstract] [Full Text] [Related]
4. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
5. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
van den Brink RH; van Melle JP; Honig A; Schene AH; Crijns HJ; Lambert FP; Ormel J
Am Heart J; 2002 Aug; 144(2):219-25. PubMed ID: 12177637
[TBL] [Abstract][Full Text] [Related]
6. [Mirtazapine--the new standard].
Fortschr Neurol Psychiatr; 1999 Aug; 67(8 Suppl):1-4. PubMed ID: 10511867
[No Abstract] [Full Text] [Related]
7. Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction.
Tulner DM; Smith OR; de Jonge P; van Melle JP; Slomp J; Storm H; Quere M; den Boer JA; Honig A; Korf J
Neuropsychobiology; 2009; 59(2):87-95. PubMed ID: 19325251
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers in depressed post-myocardial infarction patients.
Schins A; Tulner D; Lousberg R; Kenis G; Delanghe J; Crijns HJ; Grauls G; Stassen F; Maes M; Honig A
J Psychiatr Res; 2005 Mar; 39(2):137-44. PubMed ID: 15589561
[TBL] [Abstract][Full Text] [Related]
9. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
10. Cessation of complex visual hallucinations during treatment with mirtazapine.
Koethe D; Dietl T; Leweke FM; Friess E
Pharmacopsychiatry; 2007 Mar; 40(2):82-3. PubMed ID: 17447179
[No Abstract] [Full Text] [Related]
11. Mechanism of action of mirtazapine: dual action or dual effect?
Norman TR
Aust N Z J Psychiatry; 2004 Apr; 38(4):267-9; author reply 269. PubMed ID: 15038809
[No Abstract] [Full Text] [Related]
12. Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression.
Gupta R; Gupta K; Tripathi AK; Bhatia MS; Gupta LK
Pharmacology; 2016; 97(3-4):184-8. PubMed ID: 26854819
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine: a newer antidepressant.
Hartmann PM
Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.
Kang RH; Chang HS; Wong ML; Choi MJ; Park JY; Lee HY; Jung IK; Joe SH; Kim L; Kim SH; Kim YK; Han CS; Ham BJ; Lee HJ; Ko YH; Lee MS; Lee MS
J Psychopharmacol; 2010 Dec; 24(12):1755-63. PubMed ID: 19493959
[TBL] [Abstract][Full Text] [Related]
15. [Comparative efficacy of remeron (mirtazapine) and amitriptyline in treatment of patients with depression of moderate intensity].
Iakovlev VA; Belinskiĭ AV; Dorovskikh IV; Zhbrykunov VL
Voen Med Zh; 2000 Oct; 321(10):27-9. PubMed ID: 11334006
[No Abstract] [Full Text] [Related]
16. Mirtazapine-associated hyponatremia in an elderly patient.
Famularo G; Gasbarrone L; De Virgilio A; Minisola G
Ann Pharmacother; 2009 Jun; 43(6):1144-5. PubMed ID: 19435965
[No Abstract] [Full Text] [Related]
17. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine--a new antidepressant.
Med Lett Drugs Ther; 1996 Dec; 38(990):113-4. PubMed ID: 8988154
[No Abstract] [Full Text] [Related]
19. Successful antidepressive treatment with mirtazapine following lung transplantation.
Fusar-Poli P; Martinelli V; Politi P; Hobson R
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1745-6. PubMed ID: 18572297
[No Abstract] [Full Text] [Related]
20. Depressed in-patients respond differently to imipramine and mirtazapine.
Bruijn JA; Moleman P; Mulder PG; van den Broek WW
Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
